STOCKHOLDERS' EQUITY

Accumulated Other Comprehensive Income

The changes in accumulated other comprehensive income (loss) are included in the table below.



	Year Ended December 31, 2019
	Unrealized Gains and Losses on Available-for Sale Securities			Foreign Currency Items		Total
Beginning balance	$	(6	)	$	122	$	116
Amounts reclassified from accumulated other comprehensive income (loss)	8			—		8
Ending balance	$	2		$	122	$	124



	Year Ended December 31, 2018
	Unrealized Gains and Losses on Available-for Sale Securities			Foreign Currency Items		Total
Beginning balance	$	(23	)	$	122	$	99
Amounts reclassified from accumulated other comprehensive income	17			—		17
Ending balance	$	(6	)	$	122	$	116

Stock Repurchase Program

On November 1, 2007, the Company announced its Board authorized the repurchase of up to $50 million of the Company’s common stock. In addition, on October 22, 2014, the Board authorized another $30 million under the share repurchase program. The Company may repurchase its stock for cash in the open market in accordance with applicable securities laws. The timing and amount of any stock repurchase will depend on share price, corporate and regulatory requirements, economic and market conditions, and other factors. The stock repurchase authorization has no expiration date, does not require the Company to repurchase a specific number of shares, and may be modified, suspended, or discontinued at any time.

In December 2019, the Company repurchased 387,309 shares for $2.7 million at the average cost of $7.08 per share. There were no stock repurchases during the year ended December 31, 2018. During the year ended December 31, 2017, the Company repurchased 48,687 shares for $328,000 at an average cost of $6.73 per share, net of transaction costs through open market repurchases. As of December 31, 2019, approximately $30.6 million of the Company's common stock may yet be purchased. During the first quarter of 2020, the Company repurchased an additional 587,989 shares for $4.4 million at an average cost of $7.52 per share leaving approximately $26.2 million for purchases of the Company’s common stock.